Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP429966.RAMgi_RinByTqG3rsd1ayCA8ZSplls8DDcIFz8b6ihrOs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP429966.RAMgi_RinByTqG3rsd1ayCA8ZSplls8DDcIFz8b6ihrOs130_assertion type Assertion NP429966.RAMgi_RinByTqG3rsd1ayCA8ZSplls8DDcIFz8b6ihrOs130_head.
- NP429966.RAMgi_RinByTqG3rsd1ayCA8ZSplls8DDcIFz8b6ihrOs130_assertion description "[The frequency of TAP1, LMP2 and tapasin loss varied between 33% of primary adenocarcinomas, 40% of HIN to approximately 67% of metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429966.RAMgi_RinByTqG3rsd1ayCA8ZSplls8DDcIFz8b6ihrOs130_provenance.
- NP429966.RAMgi_RinByTqG3rsd1ayCA8ZSplls8DDcIFz8b6ihrOs130_assertion evidence source_evidence_literature NP429966.RAMgi_RinByTqG3rsd1ayCA8ZSplls8DDcIFz8b6ihrOs130_provenance.
- NP429966.RAMgi_RinByTqG3rsd1ayCA8ZSplls8DDcIFz8b6ihrOs130_assertion SIO_000772 14750179 NP429966.RAMgi_RinByTqG3rsd1ayCA8ZSplls8DDcIFz8b6ihrOs130_provenance.
- NP429966.RAMgi_RinByTqG3rsd1ayCA8ZSplls8DDcIFz8b6ihrOs130_assertion wasDerivedFrom befree-2016 NP429966.RAMgi_RinByTqG3rsd1ayCA8ZSplls8DDcIFz8b6ihrOs130_provenance.
- NP429966.RAMgi_RinByTqG3rsd1ayCA8ZSplls8DDcIFz8b6ihrOs130_assertion wasGeneratedBy ECO_0000203 NP429966.RAMgi_RinByTqG3rsd1ayCA8ZSplls8DDcIFz8b6ihrOs130_provenance.